Skip to main content

Table 1 Baseline Characteristics of total participants

From: Prevalence and associated factors of premature discontinuation of antiplatelet therapy after ischemic stroke: a nationwide population-based study

Characteristics

All

n (%) or mean ± SD

Total

4621 (100%)

Sex

 Male

2550 (56.2%)

 Female

2071 (43.8%)

Age (years)

 Mean

66.4 ± 12.3

 20–49

481 (10.4%)

 50–59

864 (18.7%)

 60–69

1267 (27.4%)

 70–79

1437 (31.1%)

 ≥ 80

572 (12.4%)

Income

 High

1901 (41.1%)

 Middle

1468 (31.8%)

 Low

1252 (27.1%)

Residential area

 Urban

3917 (84.8%)

 Rural

704 (15.2%)

Health insurance

 Medicare

4287 (92.8%)

 Medical aid

334 (7.2%)

Charlson comorbidity index

 < 3

2215 (47.9%)

 3–5

2149 (46.5%)

 ≥ 6

257 (5.6%)

Initiated antiplatelets

 Aspirin

1688 (36.5%)

 Clopidogrel

2170 (47.0%)

 Dual therapy

763 (16.5%)

Number of prescribed medications

 < 4

771 (16.7)

 4–7

2953 (63.9)

 ≥ 8

897 (19.4)

Average duration of antiplatelets (days)

541.1 ± 354.5

  1. SD Standard deviation